The Indian government headed by Prime Minister Manmohan Singh, who is known as the architect of the country's liberalisation and economic reforms, is inching towards a "protectionist" regime, top......
The US pharma industry has expressed concern over deteriorating intellectual property environment in India, alleging that patent rights in the country are unreasonably denied. "PhRMA remains......
Global drugmakers, battered by recent intellectual property decisions in India, are girding for a landmark court ruling next week with broad consequences for their ability to sell lucrative......
Months after its patent for a cancer medication was revoked by India, American firm Pfizer has told US lawmakers that New Delhi is undermining intellectual property by misuse of its......
US industry groups on Wednesday called for the United States to increase pressure on India to reform high-tech, agricultural and pharmaceutical policies they said block US exports and damage......